A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

CompletedOBSERVATIONAL
Enrollment

323

Participants

Timeline

Start Date

August 2, 2013

Primary Completion Date

September 4, 2014

Study Completion Date

September 4, 2014

Conditions
Retinal Vein OcclusionMacular Edema
Interventions
DRUG

Anti-VEGF

Patients with retinal vein occlusion or diabetic macular edema receiving anti-VEGF injection(s) in accordance with standard of care practices. This is a retrospective chart review study.

Trial Locations (1)

Unknown

San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01918371 - A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema | Biotech Hunter | Biotech Hunter